Publicaciones en colaboración con investigadores/as de Claude Bernard University Lyon 1 (13)

2021

  1. Bringing onco‐innovation to Europe’s healthcare systems: The potential of biomarker testing, real world evidence, tumour agnostic therapies to empower personalised medicine

    Cancers, Vol. 13, Núm. 3, pp. 1-12

2019

  1. Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes

    Hepatology, Vol. 69, Núm. 5, pp. 2214-2231

2018

  1. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

    The Lancet Respiratory Medicine, Vol. 6, Núm. 10, pp. 771-781

2017

  1. Predictors of responses to immune checkpoint blockade in advanced melanoma

    Nature Communications, Vol. 8, Núm. 1

2016

  1. PDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation

    Journal of Autoimmunity, Vol. 67, pp. 8-18

  2. ΔNp63α silences a miRNA program to aberrantly initiate a wound-healing program that promotes TGFβ-induced metastasis

    Cancer Research, Vol. 76, Núm. 11, pp. 3236-3251

2012

  1. Detectable clonal mosaicism and its relationship to aging and cancer

    Nature Genetics, Vol. 44, Núm. 6, pp. 651-658

  2. Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle

    Virology, Vol. 425, Núm. 1, pp. 31-39

2011

  1. Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: An ANOCEF phase II trial

    Journal of Clinical Oncology, Vol. 29, Núm. 22, pp. 3050-3055

2010

  1. Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors

    Journal of Gene Medicine, Vol. 12, Núm. 12, pp. 956-967

2009

  1. Identification of replication-competent HSV-1 Cgal+ strain signaling targets in human hepatoma cells by functional organelle proteomics

    Molecular and Cellular Proteomics, Vol. 8, Núm. 4, pp. 805-815

  2. Identification of replication-competent HSV-1 Cgal+ strain targets in a mouse model of human hepatocarcinoma xenograft

    Journal of Proteomics, Vol. 73, Núm. 1, pp. 153-160

  3. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection

    Journal of Virology, Vol. 83, Núm. 16, pp. 8012-8020